[Syndrome of chronic overdose of insulin and hypoglycemic sulfanilamide drugs].
Clinical features, pathogenesis and treatment of the syndrome of chronic overdosage of insulin and hypoglycemic sulpha drugs are discussed. The typical features of this syndrome were found not only in type I and II diabetes mellitus patients who were treated with insulin but also in those who were given large dosages of hypoglycemic sulpha drugs. Treatment of this syndrome has been recommended.
Arzumetova
D S
DS
Saburenko
M B
MB
Shagazatova
B Kh
BKh
Zabikhodzhaeva
G Z
GZ
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced* / Q000188:drug therapy; D007003:Hypoglycemia / Q000139:chemically induced* / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects*; D007333:Insulin Resistance; D013424:Sulfanilamides / Q000008:administration & dosage / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D007328:Insulin; D013424:Sulfanilamides
Sindrom khronicheskoĭ peredozirovki insulina i sakharosnizhaiushchikh sul'fanilamidnykh preparatov.